Research progress on eosinophilic bronchiectasis: a new inflammatory phenotype
Medical Journal of Chinese People′s Liberation ArmyVol. 50, Issue 8, Pages: 1022-1028(2025)
Review|更新时间:2025-09-16
分享给微信好友或者朋友圈
导出参考文献
Research progress on eosinophilic bronchiectasis: a new inflammatory phenotype
“The latest research has found that 20% to 30% of patients with bronchiectasis experience eosinophilia, known as eosinophilic bronchiectasis. Experts suggest using it as a treatment for inflammatory diseases, providing new ideas for disease management.”
作者机构:
兰州大学第二医院呼吸科,甘肃兰州 730030
作者简介:
E-mail: weihd@lzu.edu.cn
基金信息:
National Natural Science Foundation of China(81960014)
Shi Lei,Xia Rong,Wang Dan,et al.Research progress on eosinophilic bronchiectasis: a new inflammatory phenotype[J].Medical Journal of Chinese People′s Liberation Army,2025,50(08):1022-1028.
Shi Lei,Xia Rong,Wang Dan,et al.Research progress on eosinophilic bronchiectasis: a new inflammatory phenotype[J].Medical Journal of Chinese People′s Liberation Army,2025,50(08):1022-1028. DOI: 10.11855/j.issn.0577-7402.1949.2025.0428.
Research progress on eosinophilic bronchiectasis: a new inflammatory phenotype
Expression levels of serum copeptin, secretory phospholipase A2-X and pro- and anti-in fl ammatory cytokines in bronchiectasis patients with non-tuberculosis mycobacterium infection
Related Author
Shi Lei
Xia Rong
Wang Dan
Li Fang-Wei
Wei Hai-Dong
Ru Chu-Hui
Chen Ai-Feng
He Fei
Related Institution
Department of Respiratory, Affiliated Hangzhou Chest Hospital, Zhejiang University School of Medicine